by Bianca Garilli, ND, IFMCP, USMC Veteran Introduction SARS-CoV-2 (COVID-19) began its destructive path in China in late 2019 and spread, quite literally, across the globe at speeds faster than most could have ever imagined. Worldwide, the COVID-19 virus has left (at the time of this writing) over 190,000 people dead, and nearly 2.7 million infected based on the limited testing that most countries have employed. And the trajectory of the global curve is still uncertain. The fight is real,…

by Lewis Chang, PhD Introduction A quick search on ClinicalTrials.gov identified, as of this writing, 58 quercetin-related clinical intervention studies that are currently ongoing (19) or have been completed (39). Diverse health conditions, such as chronic obstructive pulmonary disease, type 2 diabetes, endothelial dysfunction, dyslipidemia, stroke, hepatitis C, acid reflux, inflammation, and oxidative stress, are the subject of interest. And in recent days quercetin’s role in immune health is getting a lot of attention as well. So what exactly is…

by Michael Stanclift, ND Introduction While vaccines and targeted therapies are in development for the treatment of COVID-19, some researchers are looking to known natural molecules as therapeutic agents. Two promising treatments for COVID-19, hydroxychloroquine and ivermectin, are derivatives of naturally occurring substances. Some researchers are interested in a compound from green tea with antiviral and anti-inflammatory properties. Chemists looking at computer models of the virus (SARS-CoV-2) that causes COVID-19 believe epigallocatechin gallate (EGCG) from green tea will have high…

COVID-19 April 6, 2020 Update On April 2nd, the number of COVID-19 cases reached 1 million worldwide. The US currently has over 300,000 reported cases, more than any other country in the world. Amid the uncertainty around the pandemic, the US is also learning so much more about the novel coronavirus. Epidemiologists and infectious disease experts recently published what they had learned based on existing data in JAMA Viewpoint. Below are some of the highlights.1 How does SARS-CoV-2 spread? The…

by Michael Stanclift, ND Vitamin C helps with immune system function, but due to its ubiquity, it is often underappreciated clinically. With the current COVID-19 pandemic clinicians are in search of clinical tools that are relatively easy to acquire, safe, and effective. Vitamin C (AKA ascorbic acid/ascorbate) plays an important role in immune function with Swiss Army knife-like utility. We are one of the rare animals that lack the ability to make vitamin C within our body, so we must…

COVID-19 April 2, 2020 Update Currently, the diagnosis of SARS-CoV-2 infection heavily relies on RT-PCR-based viral RNA detection method. Although the test has high sensitivity (i.e., true positive rate), there are challenges with the test that may cause delay of a confirmed diagnosis, thereby impacting timing of treatment and ability to control further spread of the virus. Here are some variables: Test sample collected at different stage of infection: The viral RNA test has high sensitivity in the early stage…

COVID-19 March 31, 2020 Update Keeping the immune system healthy is on most people’s minds during the current COVID-19 pandemic. According to epidemiological data, smoking increases susceptibility and severity of flu caused by the influenza virus.1 And experimental data have shown that cigarette smoke directly inhibits epithelial antiviral pathways and increases replication of influenza virus.2 There are also data showing higher mortality among smokers in the 2012 outbreak caused by a coronavirus known as MERS-CoV.3 However, as SARS-CoV-2 is a…

by Kara Fitzgerald, ND It looks like pyroptosis, a novel form of inflammatory cell death, may be a cause of the increased virulence of COVID-19 (although it was seen in SARS-CoV-1, too). Pyroptosis initiates the upregulation of inflammasome NLRP31 via caspase-1 proteases in the canonical pathway. Other caspases can also upregulate the inflammasome initiated by a variety of triggers. The end results of NLRP3 upregulation include IL-1β and IL-18 production and cell death. In COVID-19 patients, higher serum IL-1β (a…

COVID-19 March 30, 2020 Update Most of us are exercising physical distancing, avoiding running unnecessary errands, and other control measures in order to minimize person-to-person transmission of COVID-19. The goal is to “flatten the curve,” to delay the rapid spread of the novel coronavirus, thereby reducing the surge of illnesses in a very short time and allowing the healthcare system to breathe, to accommodate, to provide proper patient care. However, how long can (or should) schools remain closed, businesses shut,…

(Coronavirus) COVID-19 March 27, 2020 Update Two Research Letters published online March 26th in the JAMA described 3 cases of possible vertical transmission.1,2 In the first report,1 an infant girl was delivered by cesarean in a negative-pressure isolation room. She had no symptoms and was immediately quarantined. The mother with COVID-19 wore an N95 mask and did not hold the infant. Test results 2 hours after birth showed higher IgM antibody level. Because IgM antibodies do not usually appear until…